KR100362352B1 - Self tanning composition sprayed in the form of foam - Google Patents
Self tanning composition sprayed in the form of foam Download PDFInfo
- Publication number
- KR100362352B1 KR100362352B1 KR1019970020524A KR19970020524A KR100362352B1 KR 100362352 B1 KR100362352 B1 KR 100362352B1 KR 1019970020524 A KR1019970020524 A KR 1019970020524A KR 19970020524 A KR19970020524 A KR 19970020524A KR 100362352 B1 KR100362352 B1 KR 100362352B1
- Authority
- KR
- South Korea
- Prior art keywords
- alkyl
- polyoxyethylene
- olefin
- monovalent metal
- metal salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/596—Mixtures of surface active compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dispersion Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
본 발명은 거품 형태로 분사되는 피부 착색료 조성물에 관한 것으로서, 디하이드록시아세톤(dihydroxyacetone; DHA), 계면활성제 및 에어로졸 분사제를 함유함으로써, 피부에 균일하게 도포되어 얼룩이 생기지 않고, 끈적임이 없으면서 흡수력이 높아 의복, 침구등에 묻어나지 않으며, 장기간 안정하게 유지시킬 수 있는 거품분사형 피부 착색료 조성물을 제공할 수 있다.The present invention relates to a skin colorant composition sprayed in the form of a foam, comprising dihydroxyacetone (DHA), a surfactant and an aerosol propellant, which is uniformly applied to the skin without staining, without being sticky, absorbent power It is possible to provide a foam-injection skin colorant composition that can be stably maintained for a long time without being buried in clothing, bedding, and the like.
Description
본 발명은 거품 형태로 분사되는 피부 착색료 조성물에 관한 것으로서, 보다 상세하게는 디히드록시아세톤(dihydroxyacetone; DHA), 계면활성제 및 에어로졸 분사제를 함유함으로써, 피부에 균일하게 도포되어 얼룩이 생기지 않고, 끈적임이 없으면서 흡수력이 높아 의복, 침구등에 묻어나지 않으며, 장기간 안정하게 유지시킬 수 있는 거품분사형 피부 착색료 조성물에 관한 것이다.The present invention relates to a skin colorant composition sprayed in the form of a foam, and more particularly, by containing dihydroxyacetone (DHA), a surfactant and an aerosol propellant, it is uniformly applied to the skin without staining, sticky The present invention relates to a foam-coated skin colorant composition which can be kept stable for a long time without being absorbed in clothes, bedding and the like without high absorption power.
DHA는 1920년대 부터 당뇨병 치료제 등의 의약용으로 사용되어 왔으며, 1950년 대에 피부를 착색시키는 효과가 발견된 후에는 1950년대 후반부터 피부를 착색시키기 위한 용도로 사용되었다. 따라서, 오늘날 DHA는 피부를 다갈색으로 착색시킴으로서 일광욕에 의하지 않고도 피부를 태운 것과 유사한 외관을 주는 화장품, 일명 Self-Tanning 제품에 주로 사용되고 있다.DHA has been used for medicines such as diabetes treatment since the 1920s, and after the discovery of the skin coloring effect in the 1950s, DHA has been used for coloring the skin since the late 1950s. Therefore, today, DHA is mainly used in cosmetics, also known as self-tanning products, which give the appearance of burning skin without sunbathing by coloring the skin dark brown.
이 DHA는 피부각질층의 아민, 펩타이드, 유리 아미노산과 반응하여 색상을 띤 고분자물질로 변화시키는 원리로 피부를 착색시키는 것으로, 각질층이 탈락함에 따라 피부는 점차 원래의 색으로 회복되게 된다. 따라서, 현재까지 많은 제품들이DHA를 이용하여 피부를 착색시키기 위한 용도로 개발되어 왔으며 이들은 크림, 로션 등의 유액상으로 제공되어 왔다. 그러나, 현재까지 이러한 제형의 제품들은, 착색 반응에 적합한 pH가 5∼6정도의 산성범위이고, 아민류 등의 성분과 혼용성이 없고 강산성, 알칼리성의 pH 범위에서 쉽게 변성되는 성질을 지니고 있기 때문에, 제형이 매우 불안정하다. 또한, 제품을 손으로 펴바를 때 불균일하게 도포되고, 도포량을 육안으로 정확히 판별할 수 없기 때문에 균일한 착색이 이루어지지 않고 얼룩이 나타나는 문제점이 있다. 그리고, 도포시 피부에서 끈적임이 느껴지면서 흡수가 늦으므로 의복, 침구에 묻어나는 문제점이 있다.This DHA is used to color the skin by reacting with amines, peptides, and free amino acids in the stratum corneum to produce a colored polymer. As the stratum corneum is removed, the skin gradually returns to its original color. Thus, many products have been developed for the purpose of coloring the skin using DHA so far, and they have been provided in the form of emulsions such as creams and lotions. However, until now, products of such formulations have an acidic pH range of about 5 to 6 suitable for coloring reactions, are incompatible with components such as amines, and have properties of being easily denatured in a strongly acidic and alkaline pH range. The formulation is very unstable. In addition, when the product is spread by hand, it is unevenly applied, and since the coating amount cannot be accurately determined by the naked eye, there is a problem in that uneven coloring is not made and stains appear. And, when the coating is felt sticky in the skin and absorption is late, there is a problem that is buried in clothing, bedding.
따라서, 상기한 단점들을 개선하기 위해서 내용물의 점도를 조절하거나 스프레이 타입으로 분사하는 형태의 제품들이 시도되었으나, 만족할 만한 결과를 얻지 못하고 있는 실정이다.Therefore, in order to remedy the above disadvantages, there have been attempted products in the form of adjusting the viscosity of the contents or spraying in a spray type, but have not obtained satisfactory results.
이에 본 발명자는 상기의 문제점을 해결하기 위해 예의 연구를 거듭한 결과, DHA, 계면활성제 및 에어로졸 분사제를 함유함으로써, 내용물을 거품분사형으로 사용할 수 있고, 제형의 불균일성, 불균일한 착색, 사용할 때의 불편함등의 문제점을 개선할 수 있음을 발견하고 본 발명을 완성하게 되었다.Accordingly, the present inventors have diligently studied to solve the above problems, and as a result, by containing DHA, surfactants and aerosol propellants, the contents can be used in the form of foam spraying, and the nonuniformity of the formulation, nonuniform coloring, The present invention has been found to be able to improve problems such as inconvenience.
즉, 본 발명의 목적은 사용할 때 피부에 균일하게 도포되어 얼룩이 생기지 않으며, 끈적임이 없으면서 흡수력이 높아 사용감이 좋고, 장기간 안정하게 유지시킬 수 있는 거품분사형 피부 착색료 조성물을 제공하는 것이다.That is, it is an object of the present invention to provide a foam-coated skin colorant composition that can be uniformly applied to the skin when used, does not cause stains, has a high absorbency without stickiness, has a good feeling of use, and can be stably maintained for a long time.
상기한 목적을 달성하기 위하여, 본 발명에 따른 거품분사형 피부 착색료 조성물은 조성물 총 중량에 대하여 디하이드록시아세톤(DHA)를 1.0∼20중량%, 계면활성제를 0.1∼20중량%의 양으로 함유하는 에어로졸 원액과 에어로졸 분사제로 이루어짐을 특징으로 한다.In order to achieve the above object, the foaming skin colorant composition according to the present invention contains 1.0 to 20% by weight of dihydroxyacetone (DHA) and 0.1 to 20% by weight of surfactant based on the total weight of the composition. It is characterized by consisting of aerosol stock solution and aerosol propellant.
이하 본 발명을 보다 상세히 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명의 거품분사형 피부 착색료 조성물은, 에어로졸 원액과 에어로졸 분사제로 이루어져 있으며, 상기 원액은 조성물 총 중량에 대하여 DHA를 1.0∼20중량%, 계면활성제를 0.1∼20중량%의 양으로 함유한다.The foam-injection skin colorant composition of the present invention comprises an aerosol stock solution and an aerosol propellant, wherein the stock solution contains 1.0 to 20% by weight of DHA and 0.1 to 20% by weight of surfactant based on the total weight of the composition.
본 발명에 있어서, DHA는 착색이 일어나되 내용물이 장기간 안정하게 유지될 수 있도록 조성물 총 중량에 대하여 1.0∼20중량% 양으로 함유한다.In the present invention, DHA is contained in an amount of 1.0 to 20% by weight based on the total weight of the composition so that coloring can occur but the content can be stably maintained for a long time.
본 발명의 피부 착색료 조성물에서 내용물의 분리, 침전등을 막아주고 거품분사를 위해 사용되는 에어로졸 분사제와의 상용성을 목적으로 사용되는 계면활성제로는 양이온성, 음이온성, 비이온성 및 양쪽이온성 중에서 선택된 1종 이상을 혼합하여, 조성물 총 중량에 대하여 0.1∼20중량%의 양으로 함유한다. 구체적인 예로는, 염화알킬트리메틸암모늄, 염화디알킬디메틸암모늄, 염화알킬디폴리옥시에틸렌메틸암모늄 등의 양이온 계면활성제, 알릴-알킬설포네이트의 일가 금속염, 알킬설페이트의 일가 금속염, 폴리옥시에틸렌알킬설페이트의 일가 금속염, 알릴-올레핀설포네이트의 일가금속염, 올레핀설페이트의 일가금속염, 폴리옥시에틸렌올레핀설페이트의 일가금속염, 메틸알킬타우레이트의 일가금속염등의 음이온 계면활성제, 폴리옥시에틸렌알킬에테르, 알킬폴리사카라이드, 폴리옥시에틸렌알킬에스테르, 폴리옥시에틸렌소르비탄알킬에스테르, 폴리옥시에틸렌올레핀에텔, 올레핀폴리사카라이드, 폴리옥시에틸렌올레핀에스테르, 폴리옥시에틸렌소르비탄올레핀에스테르, 디메치콘코폴리올, 폴리옥시에틸렌토코페릴에테르 등의 비이온성 계면활성제, 코카미도프로필베타인, 알킬베타인, 올레핀베타인 등의 양쪽성 계면활성제 등이 있다.Surfactants used for the purpose of compatibility with the aerosol propellant used to prevent separation and sedimentation of the contents in the skin colorant composition of the present invention and foam spraying are cationic, anionic, nonionic and zwitterionic. At least one selected from among them is mixed and contained in an amount of 0.1 to 20% by weight based on the total weight of the composition. Specific examples include cationic surfactants such as alkyltrimethylammonium chloride, dialkyldimethylammonium chloride and alkyldipolyoxyethylenemethylammonium chloride, monovalent metal salts of allyl-alkylsulfonate, monovalent metal salts of alkyl sulfate, and polyoxyethylene alkyl sulfate. Anionic surfactants, polyoxyethylene alkyl ethers, alkyl polysaccharides, such as monovalent metal salts, monovalent metal salts of allyl-olefinsulfonate, monovalent metal salts of olefin sulfates, monovalent metal salts of polyoxyethylene olefin sulfates, and monovalent metal salts of methylalkyltaurates , Polyoxyethylene alkyl ester, polyoxyethylene sorbitan alkyl ester, polyoxyethylene olefin ether, olefin polysaccharide, polyoxyethylene olefin ester, polyoxyethylene sorbitan olefin ester, dimethicone copolyol, polyoxyethylene tocopheryl Nonionic surfactants such as ethers And amphoteric surfactants such as cocamidopropyl betaine, alkyl betaine and olefin betaine.
본 발명의 거품분사형 피부 착색료 조성물에서 내용물을 용기로부터 방출시키기 위한 분사제로는 에어로졸 용기에 통상적으로 사용해오고 있는 액화 석유가스, 압축가스 또는 공기등 제한없이 선택하여 사용할 수 있으며, 구체적인 예로는 트리클로로플루오로메탄, 디클로로테트라플루오로메탄, 모노클로로디플루오로메탄, 트리클로로트리플루오로메탄, 디메틸에테르, 프로판, n-부탄, 이소부탄 등의 액화가스, 압축 질소가스, 압축 산소가스, 압축공기 등의 압축가스, 상압에서 사용자의 가압에 의해 혼입되는 공기 등이 있으며, 이들중에서 선택된 1종 이상을 혼합하여 사용한다. 분사제의 사용량은 조성물 총 중량에 대해 1.0∼40중량%, 바람직하게는 5∼15중량%이다. 한편, 압축가스와 공기를 사용하는 경우 압력이 8.5 kgf/cm2이하가 되도록 하여야 하고, 공기의 경우 공기 혼입이 가능한 용기에 충진되어야 한다.As a propellant for releasing the contents from the container in the foam-injection skin colorant composition of the present invention can be selected and used without limitation, such as liquefied petroleum gas, compressed gas or air that is commonly used in aerosol containers, specific examples are trichloro fluorine Liquefied gases such as romethane, dichlorotetrafluoromethane, monochlorodifluoromethane, trichlorotrifluoromethane, dimethyl ether, propane, n-butane, isobutane, compressed nitrogen gas, compressed oxygen gas, compressed air, etc. Compressed gas, air mixed by the user's pressurization at normal pressure, and the like, and at least one selected from these are mixed and used. The amount of propellant used is 1.0 to 40% by weight, preferably 5 to 15% by weight, based on the total weight of the composition. On the other hand, in the case of using compressed gas and air, the pressure should be below 8.5 kg f / cm 2 , and in the case of air, the container should be filled with air.
또한, 본 발명에 따른 거품분사형 피부 착색료 조성물은 매끄러운 사용감과 퍼짐성을 주기 위해 적량의 점증제와 보습제등을 함유할 수 있으며, pH의 조절과 안정화를 위해 염기와 완충용액을 사용할 수 있다.In addition, the foam injection-type skin colorant composition according to the present invention may contain an appropriate amount of thickeners and moisturizers to give a smooth feeling of use and spreadability, and may use a base and a buffer solution for controlling and stabilizing pH.
이하, 실시예를 들어 본 발명을 보다 상세히 설명하지만, 본 발명이 이들 실시예에만 한정되는 것은 아니다.Hereinafter, although an Example is given and this invention is demonstrated in detail, this invention is not limited only to these Examples.
<실시예 1><Example 1>
<실시예 2><Example 2>
<실시예 3><Example 3>
<비교예 1> 논 에어로졸 스프레이 타입<Comparative Example 1> Non-Aerosol Spray Type
<비교예 2> 로션 타입<Comparative Example 2> Lotion Type
<비교예 3> 로션 타입<Comparative Example 3> Lotion Type
<시험예 1><Test Example 1>
상기 실시예 및 비교예의 피부 착색료 조성물를 일정크기의 다공성 매질에 특정 아미노산을 함침시킨 Test sheet에 도포하여 착색의 균일정도를 측정하고, 그 결과를 표 1에 나타내었다.Skin pigment composition of the Examples and Comparative Examples was applied to a test sheet impregnated with a specific amino acid in a porous medium of a certain size to measure the uniformity of the pigmentation, and the results are shown in Table 1.
<시험예 2><Test Example 2>
상기 실시예 및 비교예의 제품을 20∼30세 여성 30명을 대상으로 비교품평을 실시하고, 그 결과를 표 2에 나타내었다.A comparative review was conducted on 30 women aged 20 to 30 years with the products of Examples and Comparative Examples, and the results are shown in Table 2.
상기 표 1과 표 2에서 알 수 있는 바와 같이, 실시예 1∼3의 피부 착색료 조성물의 경우 사용시 끈적임이 적고 퍼짐성이 우수하므로 산뜻함을 느낄 수 있고, 의복이나 침구에 묻어나는 등의 불편함이 개선되었다. 또한 특정면적의 도포에 사용되는 시료량이 비교예에 비하여 적으므로, 동량을 취할 경우 실시예가 비교예에 비해 유사한 강도의 착색이 골고루 일어날 것임을 예측할 수 있다.As can be seen in Table 1 and Table 2, in the case of the skin colorant composition of Examples 1 to 3, less stickiness and excellent spreadability, the freshness can be felt, and discomfort such as staining on clothes or bedding is improved. It became. In addition, since the amount of sample used for the application of a specific area is smaller than that of the comparative example, it can be predicted that the same amount of coloring will occur evenly compared to the comparative example when the same amount is taken.
한편, 사람을 대상으로 한 품평에서 실시예 1, 2의 경우 착색이 엷게 이루어지는 경향이 있었는데 이는 거품인 관계로 사용자가 비교적 소량을 사용하게되는경향과 함께 충진가스의 부가로 인해 실제 DHA의 함량이 적어진 것이 원인이며, 실시예 3에서와 같이 DHA의 함량을 늘림으로써 착색의 강도를 높일 수 있다.On the other hand, in Examples 1 and 2, the coloring tended to be light in the human subject's review, which is a bubble and the user tends to use a relatively small amount. The reason is that it is less, and the intensity of coloring can be increased by increasing the content of DHA as in Example 3.
이상에서와 같이 본 발명의 거품분사형 피부 착색료 조성물은 디하이드록시아세톤(DHA)과 계면활성제 및 분사제를 함유함으로써, 사용할 때 끈적임이 적고 퍼짐성이 우수하며, 흡수가 빠르므로 의복이나 침구 등에 묻어나는 현상이 개선된다. 또한, 제형이 안정하므로 장기간 안정하게 유지시킬 수 있다.As described above, the foam-injection skin colorant composition of the present invention contains dihydroxyacetone (DHA), a surfactant, and a propellant, so that when used, it is less sticky, has excellent spreadability, and absorbs quickly, so that it can be applied to clothing or bedding. The phenomenon is improved. In addition, since the formulation is stable, it can be kept stable for a long time.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019970020524A KR100362352B1 (en) | 1997-05-24 | 1997-05-24 | Self tanning composition sprayed in the form of foam |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019970020524A KR100362352B1 (en) | 1997-05-24 | 1997-05-24 | Self tanning composition sprayed in the form of foam |
Publications (2)
Publication Number | Publication Date |
---|---|
KR19980084678A KR19980084678A (en) | 1998-12-05 |
KR100362352B1 true KR100362352B1 (en) | 2003-01-24 |
Family
ID=37490732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019970020524A Expired - Lifetime KR100362352B1 (en) | 1997-05-24 | 1997-05-24 | Self tanning composition sprayed in the form of foam |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100362352B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2403897C2 (en) * | 2005-12-15 | 2010-11-20 | Кимберли-Кларк Ворлдвайд, Инк. | Tissue used with disinfectants |
KR101022988B1 (en) | 2008-07-17 | 2011-03-22 | 한국콜마 주식회사 | Aerosol-based foundation cosmetic composition and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6216411A (en) * | 1985-07-16 | 1987-01-24 | Pola Chem Ind Inc | Makeup cosmetic |
US5268166A (en) * | 1991-07-15 | 1993-12-07 | Elizabeth Arden Company, Division Of Conopco, Inc. | Cosmetic application system |
WO1994012146A1 (en) * | 1992-11-23 | 1994-06-09 | Estee Lauder, Inc. | Self-tanning cosmetic compositions and methods of using the same |
JPH07101843A (en) * | 1993-09-30 | 1995-04-18 | Shiseido Co Ltd | Self-tanning cosmetic |
-
1997
- 1997-05-24 KR KR1019970020524A patent/KR100362352B1/en not_active Expired - Lifetime
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6216411A (en) * | 1985-07-16 | 1987-01-24 | Pola Chem Ind Inc | Makeup cosmetic |
US5268166A (en) * | 1991-07-15 | 1993-12-07 | Elizabeth Arden Company, Division Of Conopco, Inc. | Cosmetic application system |
WO1994012146A1 (en) * | 1992-11-23 | 1994-06-09 | Estee Lauder, Inc. | Self-tanning cosmetic compositions and methods of using the same |
US5662890A (en) * | 1992-11-23 | 1997-09-02 | Estee Lauder, Inc. | Self-tanning cosmetic compositions and methods of using the same |
JPH07101843A (en) * | 1993-09-30 | 1995-04-18 | Shiseido Co Ltd | Self-tanning cosmetic |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2403897C2 (en) * | 2005-12-15 | 2010-11-20 | Кимберли-Кларк Ворлдвайд, Инк. | Tissue used with disinfectants |
KR101022988B1 (en) | 2008-07-17 | 2011-03-22 | 한국콜마 주식회사 | Aerosol-based foundation cosmetic composition and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
KR19980084678A (en) | 1998-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4863725A (en) | Novel clear oil-free moisturizer composition | |
JPH09501683A (en) | Cosmetic composition | |
MXPA06011962A (en) | Skin care compositions. | |
JP2003201217A (en) | Aerosol composition for hair | |
EP1924236A2 (en) | Sunless tanning composition and method of sunless tanning | |
US20040241113A1 (en) | Stable cosmetic composition comprising a self-tanning agent | |
KR100953144B1 (en) | Foam type massage mousse pack cosmetic composition using carbon dioxide as propellant | |
WO2008125406A2 (en) | Composition and method for regulating sebum flow | |
JP3929936B2 (en) | Effervescent skin coating agent | |
KR100362352B1 (en) | Self tanning composition sprayed in the form of foam | |
JP4707221B2 (en) | Aerosol composition | |
KR20180130178A (en) | Liposome and cosmetic composition comprising the same | |
US4840790A (en) | Cosmetic composition for the treatment of the hair and scalp containing in combination a poly-beta-alanine and nicotinic acid or an ester thereof | |
JP4628560B2 (en) | Aerosol composition and product thereof | |
KR101076308B1 (en) | spray type foundation composition | |
JP3616154B2 (en) | Aerosol composition | |
JP7085356B2 (en) | Aerosol hair cosmetics | |
JP3946480B2 (en) | Aerosol composition | |
KR20170119243A (en) | Cosmetic composition with high glycerin content comprising glyceryl polyacrylate | |
US10413488B2 (en) | Aerosol oil foam compositions comprising a triglyceride-based oil and surfactant | |
KR102370390B1 (en) | Cosmetic composition for anti-aging | |
JP3247787B2 (en) | Aerosol composition for hair care | |
JP2002037362A (en) | Pressurized product | |
JP3494471B2 (en) | Aerosol composition for skin care | |
WO2015037988A1 (en) | Aerosol container comprising a dermatological composition and a foaming agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19970524 |
|
PG1501 | Laying open of application | ||
A201 | Request for examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20000303 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19970524 Comment text: Patent Application |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20020423 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20021111 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20021112 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20021113 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20041223 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20061019 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20071011 Start annual number: 6 End annual number: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20081006 Start annual number: 7 End annual number: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20091021 Start annual number: 8 End annual number: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20101013 Start annual number: 9 End annual number: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20111017 Start annual number: 10 End annual number: 10 |
|
FPAY | Annual fee payment |
Payment date: 20121017 Year of fee payment: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20121017 Start annual number: 11 End annual number: 11 |
|
FPAY | Annual fee payment |
Payment date: 20131011 Year of fee payment: 12 |
|
PR1001 | Payment of annual fee |
Payment date: 20131011 Start annual number: 12 End annual number: 12 |
|
PR1001 | Payment of annual fee |
Payment date: 20141031 Start annual number: 13 End annual number: 13 |
|
FPAY | Annual fee payment |
Payment date: 20151030 Year of fee payment: 14 |
|
PR1001 | Payment of annual fee |
Payment date: 20151030 Start annual number: 14 End annual number: 14 |
|
FPAY | Annual fee payment |
Payment date: 20161010 Year of fee payment: 15 |
|
PR1001 | Payment of annual fee |
Payment date: 20161010 Start annual number: 15 End annual number: 15 |
|
EXPY | Expiration of term | ||
PC1801 | Expiration of term |